Junki Maruyama, DVM, PhD
Assistant Professor

Department of Pathology

Phone: (409) 266-6931
Email: jumaruya@utmb.edu

Junki Maruyama, DVM, PhD

  • Molecular biology, viral pathogenesis, animal models of infectious diseases, vaccine/antiviral development, and diagnostics development.

    My major passion for scientific research is in viral infectious diseases and their pathogenicity. Especially, I am interested in highly pathogenic viruses, such as Risk Group 4 agents, and the development of control methods against infectious diseases. Through my research experience, I believe that basic research is essential for the further development of countermeasures against viral infectious diseases. I have more than 13 years of experience in the field of viral pathogenesis with highly pathogenic viruses, such as highly pathogenic avian influenza virus, Ebola virus, Lassa virus, and SARS-CoV-2, which are needed to be handled in biosafety level 3 (BSL-3) or BSL-4 facilities.

    Maruyama Lab Website


  • School of Veterinary Medicine, Hokkaido University, Japan DVM Veterinary Medicine 2012
    Graduate School of Veterinary Medicine, Hokkaido University, Japan PhD Veterinary Medicine (Virology) 2016
    The University of Texas Medical Branch Postdoctoral Experimental Pathology 2022
  • Encouragement Award for Young scientists, The 153rd Meeting of the Japanese Society of Veterinary Science 2012
    Research Fellow, Program for Leading Graduate Schools, Hokkaido University 2012-2014
    Research Fellow, Japan Society for the Promotion of Science (JSPS) 2014-2016
    Postdoctoral fellow, JSPS Overseas Research Fellowship 2017-2019
    The Robert L. Harrison Award, Department of Pathology’s 26th Annual Trainee Research Day 2020
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed), National Institutes of Health 2021-2023
  • The Japanese Society of Veterinary Science 2011-
    The Japanese Society for Virology 2013-
    American Heart Association 2019-
    American Society for Virology 2020-
    Editorial Board Member, Vaccines 2021-
    Associate Editor, Frontiers in Microbiology (Virology) 2022-
  • Maruyama J, Reyna RA, Kishimoto-Urata M, Urata S, Manning JT, Harsell N, Cook R, Huang C, Nikolich-Zugich J, Makishima T, Paessler S. 2022. CD4 T-cell depletion prevents Lassa fever associated hearing loss in the mouse model. PLoS Pathog. 18(5):e1010557.
    Reyna RA, Kishimoto-Urata M, Urata S, Makishima T, Paessler S*, Maruyama J*. 2022. Recovery of anosmia in hamsters infected with SARS-CoV-2 is correlated with repair of the olfactory epithelium. Sci Rep. 12:628. *contributed equally
    Urata S*, Maruyama J*, Kishimoto-Urata M, Sattler RA, Cook R, Lin N, Yamasoba T, Makishima T, Paessler S. 2021. Regeneration profiles of olfactory epithelium after SARS-CoV-2 infection in golden Syrian hamsters. ACS Chem. Neurosci. 12(4):589-595. *contributed equally
    Maruyama J, Mateer EJ, Manning JT, Sattler R, Seregin AV, Bukreyeva N, Jones FR, Balint JP, Gabitzsch ES, Huang C, Paessler S. 2019. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs. Vaccine. 37(45): 6824-6831
    Maruyama J, Manning JT, Mateer EJ, Sattler R, Bukreyeva N, Huang C, Paessler S. 2019. Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation. mSphere. 4(5): e00428-19
    Maruyama J, Nao N, Miyamoto H, Maeda K, Ogawa H, Yoshida R, Igarashi M, Takada A. 2016. Characterization of the glycoproteins of bat-derived influenza viruses. Virology 488:43–50.
    Maruyama J, Miyamoto H, Kajihara M, Ogawa H, Maeda K, Sakoda Y, Yoshida R, Takada A. 2014. Characterization of the envelope glycoprotein of a novel filovirus, Lloviu virus. J Virol 88:99–109.
    Maruyama J, Okamatsu M, Soda K, Sakoda Y, Kida H. 2013. Factors responsible for pathogenicity in chickens of a low-pathogenic H7N7 avian influenza virus isolated from a feral duck. Arch Virol 158:2473–2478.